CHRISTOPHER BUNKA - 15 May 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Christopher Bunka/
Issuer symbol
LEXX
Transactions as of
15 May 2025
Net transactions value
$0
Form type
4
Filing time
16 May 2025, 17:39:39 UTC
Previous filing
10 Jan 2025
Next filing
30 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BUNKA CHRISTOPHER Director SUITE 100, 740 MCCURDY ROAD, KELOWNA, BRITISH COLUMBIA, CANADA /Christopher Bunka/ 16 May 2025 0001103780

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 373,543 15 May 2025 Direct F1
holding LEXX common shares 254,412 15 May 2025 Private Holding Company

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +11,000 +6.3% $0.000000 184,834 15 May 2025 Common Shares 11,000 $1.04 Direct
holding LEXX Stock Options 26,000 15 May 2025 Common Shares 26,000 $3.00 Direct
holding LEXX Stock Options 49,334 15 May 2025 Common Shares 23,334 $3.00 Direct
holding LEXX Stock Options 64,334 15 May 2025 Common Shares 15,000 $3.00 Direct
holding LEXX Stock Options 94,334 15 May 2025 Common Shares 30,000 $2.91 Direct
holding LEXX Stock Options 124,334 15 May 2025 Common Shares 30,000 $1.15 Direct
holding LEXX Stock Options 173,834 15 May 2025 Common Shares 49,500 $2.36 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100,000 common shares were issued as a restricted stock award that is subject to escrow provisions until July 7, 2025.